Hillstream BioPharma (NASDAQ:HILS) Lowered to Neutral at Dawson James

Dawson James lowered shares of Hillstream BioPharma (NASDAQ:HILS – Free Report) from a buy rating to a neutral rating in a research note published on Monday, MarketBeat reports. Hillstream BioPharma Trading Down 4.3 % Shares of HILS stock opened at $0.38 on Monday. The firm has a fifty day simple moving average of $0.38 and […]

Related Keywords

Dawson James ,Hillstream Biopharma ,Geode Capital Management ,Hillstream Biopharma Inc ,Hillstream Biopharma Company Profile ,Citadel Advisors ,Free Report ,Biopharma Trading Down ,Get Free Report ,Street Group ,Capital Management ,Hillstream Biopharma Daily ,Nasdaq Hils ,Vhils ,Medical ,Downgrade ,